WO1999054447A3 - Menschliche nukleinsäuresequenzen aus blasentumorgewebe - Google Patents

Menschliche nukleinsäuresequenzen aus blasentumorgewebe Download PDF

Info

Publication number
WO1999054447A3
WO1999054447A3 PCT/DE1999/001170 DE9901170W WO9954447A3 WO 1999054447 A3 WO1999054447 A3 WO 1999054447A3 DE 9901170 W DE9901170 W DE 9901170W WO 9954447 A3 WO9954447 A3 WO 9954447A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid sequences
tumour tissue
human nucleic
bladder tumour
Prior art date
Application number
PCT/DE1999/001170
Other languages
English (en)
French (fr)
Other versions
WO1999054447A2 (de
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Original Assignee
Metagen Gesellschaft Fuer Genomforschung Mbh
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagen Gesellschaft Fuer Genomforschung Mbh, Thomas Specht, Bernd Hinzmann, Armin Schmitt, Christian Pilarsky, Edgar Dahl, Andre Rosenthal filed Critical Metagen Gesellschaft Fuer Genomforschung Mbh
Priority to JP2000544779A priority Critical patent/JP2002512023A/ja
Priority to EP99927682A priority patent/EP1073742A2/de
Publication of WO1999054447A2 publication Critical patent/WO1999054447A2/de
Publication of WO1999054447A3 publication Critical patent/WO1999054447A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Es werden menschliche Nukleinsäuresequenzen - mRNA, cDNA, genomische Sequenzen - aus Blasentumorgewebe, die für Genprodukte oder Teile davon kodieren, und deren Verwendung beschrieben. Es werden weiterhin die über die Sequenzen erhältlichen Polypeptide und deren Verwendung beschrieben.
PCT/DE1999/001170 1998-04-21 1999-04-15 Menschliche nukleinsäuresequenzen aus blasentumorgewebe WO1999054447A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000544779A JP2002512023A (ja) 1998-04-21 1999-04-15 膀胱癌組織由来ヒト核酸配列
EP99927682A EP1073742A2 (de) 1998-04-21 1999-04-15 Menschliche nukleinsäuresequenzen aus blasentumorgewebe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19818619.3 1998-04-21
DE19818619A DE19818619A1 (de) 1998-04-21 1998-04-21 Menschliche Nukleinsäuresequenzen aus Blase-Tumor

Publications (2)

Publication Number Publication Date
WO1999054447A2 WO1999054447A2 (de) 1999-10-28
WO1999054447A3 true WO1999054447A3 (de) 2000-07-06

Family

ID=7865833

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/001170 WO1999054447A2 (de) 1998-04-21 1999-04-15 Menschliche nukleinsäuresequenzen aus blasentumorgewebe

Country Status (4)

Country Link
EP (1) EP1073742A2 (de)
JP (1) JP2002512023A (de)
DE (1) DE19818619A1 (de)
WO (1) WO1999054447A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358508B1 (en) 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
AU3316600A (en) 1999-02-22 2000-09-21 Torben F. Orntoft Gene expression in bladder tumors
US6573364B1 (en) * 1999-03-10 2003-06-03 Curagen Corporation Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
IL148798A0 (en) * 1999-09-27 2002-09-12 Quark Biotech Inc Sequences characteristic of bladder cancer
WO2001087238A2 (en) * 2000-05-17 2001-11-22 Oregon Health & Sciences University Induction of apoptosis and cell growth inhibition by protein 4.33
AU2003220387A1 (en) 2002-03-19 2003-10-08 Tularik Inc. Gene amplification in cancer
EP1590440A4 (de) * 2003-02-03 2009-03-18 Palo Alto Inst Of Molecular Me Zellabtötende moleküle und vefahren zu deren verwendung
DE10309729A1 (de) * 2003-02-26 2004-09-16 Hinzmann, Bernd, Dr. Humane Nukleinsäuresequenzen aus Harnblasenkarzinomen
JPWO2005093063A1 (ja) * 2004-03-29 2008-02-14 株式会社医学生物学研究所 固形癌診断キット及び固形癌治療用医薬
US8129340B2 (en) 2006-09-08 2012-03-06 Institut Gustave Roussy Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof
EP1961762A1 (de) * 2007-02-21 2008-08-27 Institut Gustave Roussy Proteinphosphatase-1/GADD34-Inhibitoren, deren Herstellung und Verwendung
US8420315B2 (en) * 2007-08-06 2013-04-16 Orion Genomics Llc Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001777A1 (en) * 1992-07-14 1994-01-20 Michigan Cancer Foundation Method of determining metastatic potential of tumor cells
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001777A1 (en) * 1992-07-14 1994-01-20 Michigan Cancer Foundation Method of determining metastatic potential of tumor cells
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), HOWDEN P: "Human DNA sequence from clone 328E19 on chromosome 1q12-21.2", XP002126938, Database accession no. AL022240 *
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002126939, Database accession no. AA774786 *
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002126940, Database accession no. AF131738 *
O'BRIEN, T. ET AL.: "The Angiogenic Factor Midkine Is Expressed in Bladder Cancer, and Overexpression Correlates with a Poor Outcome in Patients with invasive Cancers", CANCER RESEARCH, vol. 56, no. 11, 1 June 1996 (1996-06-01), pages 2515 - 2518, XP000857920 *
SCHMITT, A.O. ET AL.: "Exhaustive mining of EST libraries for genes differentially expressed in normal and tumor tissue", NUCLEIC ACIDS RESEARCH, vol. 27, no. 21, 1 November 1999 (1999-11-01), pages 4251 - 4260, XP002126641 *

Also Published As

Publication number Publication date
DE19818619A1 (de) 1999-10-28
JP2002512023A (ja) 2002-04-23
WO1999054447A2 (de) 1999-10-28
EP1073742A2 (de) 2001-02-07

Similar Documents

Publication Publication Date Title
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
WO1999047669A3 (de) Menschliche nukleinsäuresequenzen aus brusttumorgewebe
WO1999055858A3 (de) Menschliche nukleinsäuresequenzen aus pankreastumorgewebe
WO1999053051A3 (en) 5' ests and encoded human proteins
EP1033401A3 (de) Exprimierte Sequenzmarker und kodierte menschliche Proteine
WO1999040189A3 (en) Cdnas encoding secreted proteins
WO1999006548A3 (en) 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS
WO1999006550A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
WO1999031236A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999051727A3 (de) Menschliche nukleinsäuresequenzen aus ovarnormalgewebe
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
WO1999025825A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999006554A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
WO2000040614A3 (en) Characterization of the soc/crac calcium channel protein family
WO1999006549A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
WO2001070977A3 (en) Fibroblast growth factor receptor-like molecules and uses thereof
WO1999054353A3 (de) Menschliche nukleinsäuresequenzen aus uterusnormalgewebe
WO1999054460A3 (de) Menschliche nukleinsäuresequenzen aus normalem blasengewebe
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
WO2002020762A3 (en) Tnf receptor-like molecules and uses thereof
WO1999006553A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES
WO1998059040A3 (de) Humane katalytische telomerase-untereinheit und deren diagnostische und therapeutische verwendung
WO2000053776A3 (en) Human kallikrein-like genes
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999927682

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09673841

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999927682

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999927682

Country of ref document: EP